WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Biocryst Pharmaceuticals revenue was $450.71M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $131.5M, up 12.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCRX annual revenue was $450.7M, with 36% growth year-over-year.

BCRX past revenue growth

How has BCRX's revenue growth performed historically?

Company
36%
Industry
437.31%
Market
20.27%
BCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BCRX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BCRX revenue history

Current Revenue
$450.7M
Current Earnings
-$88.9M
Current Profit Margin
-19.7%

Be the first to know when BCRX announces revenue.

BCRX Revenue History By Year

BCRX Yearly RevenueBCRX RevenueBCRX ChangeBCRX Revenue Growth
2024-12-31$450.71M$119.30M+36.00%
2023-12-31$331.41M$60.59M+22.37%
2022-12-31$270.83M$113.66M+72.31%
2021-12-31$157.17M$139.36M+782.38%
2020-12-31$17.81M-$31.02M-63.53%
2019-12-31$48.84M$28.18M+136.45%
2018-12-31$20.65M-$4.53M-18.00%
2017-12-31$25.19M-$1.17M-4.43%
2016-12-31$26.35M-$21.90M-45.39%
2015-12-31$48.26M$34.65M+254.62%
2014-12-31$13.61M-$3.72M-21.48%
2013-12-31$17.33M-$8.96M-34.09%
2012-12-31$26.29M$6.65M+33.85%
2011-12-31$19.64M-$42.74M-68.51%
2010-12-31$62.38M-$12.21M-16.37%
2009-12-31$74.59M$18.03M+31.87%
2008-12-31$56.56M-$14.68M-20.60%
2007-12-31$71.24M$65.03M+1,046.79%
2006-12-31$6.21M$6.06M+3,990.38%
2005-12-31$151.87k-$185.03k-54.92%
2004-12-31$336.90k-$316.35k-48.43%
2003-12-31$653.26kN/AN/A
2002-12-31$0.00-$11.16M-100.00%
2001-12-31$11.16M$3.50M+45.64%
2000-12-31$7.66M$2.33M+43.77%
1999-12-31$5.33M-$2.30M-30.12%
1998-12-31$7.63M$4.93M+183.23%
1997-12-31$2.69M$40.36k+1.52%
1996-12-31$2.65M$1.77M+199.82%
1995-12-31$884.59k$150.77k+20.55%
1994-12-31$733.82kN/AN/A

1 of 3

Biocryst Pharmaceuticals Revenue FAQ

What was BCRX's revenue last quarter?

On Invalid Date, Biocryst Pharmaceuticals (NASDAQ: BCRX) reported Q4 2024 revenue of $131.53 million up 40.83% year over year. In the same quarter last year, Biocryst Pharmaceuticals's revenue was $93.40 million.

What was Biocryst Pharmaceuticals's revenue in 2024?

Biocryst Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $450.71 million, a 36% increase year over year.

How much does Biocryst Pharmaceuticals make in a day?

Based on Biocryst Pharmaceuticals annual revenue for the past five years, BCRX makes an average of $672,840.00 per day.

What was Biocryst Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Biocryst Pharmaceuticals's revenue has grown 36% year over year. This is 401.31 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Biocryst Pharmaceuticals's revenue in the past year totaled $450.71 million.

How much does Biocryst Pharmaceuticals make in a year?

Biocryst Pharmaceuticals's revenue by year for the past five years is:
  • Biocryst Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $450.71 million, a 36% increase year over year.
  • Biocryst Pharmaceuticals's annual revenue for Dec 31, 2023 was $331.41 million, a 22.37% increase from 2022.
  • Biocryst Pharmaceuticals's annual revenue for 2022 was $270.83 million, a 72.31% increase from 2021.
  • Biocryst Pharmaceuticals's annual revenue for 2021 was $157.17 million, a 782.38% increase from 2020.
  • Biocryst Pharmaceuticals's annual revenue for 2020 was $17.81 million, a 63.53% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.